证券代码：603310 证券简称：巍华新材 公告编号：2025-063 注册资本：贰仟万元整 成立日期：2005 年 8 月 12 日 浙江巍华新材料股份有限公司 关于全资子公司完成工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江巍华新材料股份有限公司全资子公司江西巍华化学有限公司（以下简称 "江西巍华"）于近日办理了法定代表人变更登记手续。经弋阳县市场监督管理 局核准，江西巍华已完成相关工商变更登记手续，并取得了新的《营业执照》。 变更后的相关工商登记信息如下： 统一社会信用代码：913611267788079051 名称：江西巍华化学有限公司 类型：有限责任公司（非自然人投资或控股的法人独资） 法定代表人：张增兴 2025 年 11 月 27 日 住所：江西省上饶市弋阳县高新技术产业园区火炬路 2 号 经营范围：许可项目：危险化学品生产（依法须经批准的项目，经相关部门 批准后在许可有效期内方可开展经营活动，具体经营项目和许可期限以相关部门 批准文件或许可证件为准）一般项目：新材料技术推广服务，化工产 ...

11月20日，巍华新材盘中下跌2.00%，截至14:03，报17.60元/股，成交4587.42万元，换手率1.40%，总 市值60.78亿元。 资金流向方面，主力资金净流出771.82万元，特大单买入0.00元，占比0.00%，卖出370.40万元，占比 8.07%；大单买入657.84万元，占比14.34%，卖出1059.27万元，占比23.09%。 责任编辑：小浪快报 资料显示，浙江巍华新材料股份有限公司位于浙江省杭州湾上虞经济技术开发区北塘东路8号，成立日 期2013年10月12日，上市日期2024年8月14日，公司主营业务涉及氯甲苯和三氟甲基苯系列产品研发、 生产和销售。主营业务收入构成为：三氟甲基苯系列79.35%，氯甲苯系列19.71%，其他(补充)0.95%。 巍华新材所属申万行业为：基础化工-化学制品-氟化工。所属概念板块包括：小盘、氟化工、新材料、 融资融券、次新股等。 截至9月30日，巍华新材股东户数1.99万，较上期减少1.68%；人均流通股9287股，较上期增加1.71%。 2025年1月-9月，巍华新材实现营业收入6.60亿元，同比减少15.18%；归母净利润1.09亿元，同比减少 ...

Core Viewpoint - Wihua New Materials (603310.SH) is acquiring a 70% stake in Jiangsu Heyutai Chemical Co., Ltd. for 154 million yuan to extend its industrial chain and enhance core competitiveness, despite Heyutai not being profitable yet [1][2]. Group 1: Acquisition Details - The acquisition will be funded through the company's own funds and bank loans, with Heyutai becoming a controlled subsidiary post-transaction [1]. - The transaction is valued at 266 million yuan, with a premium rate of 4.22% [4]. - Prior to the acquisition, Wihua New Materials provided some intermediates necessary for Heyutai's production [2]. Group 2: Financial Performance - Heyutai's projected revenues for 2024 and the first half of 2025 are 464 million yuan and 202 million yuan, respectively, with net losses of 14.12 million yuan and 4.91 million yuan [3]. - As of June 2025, Heyutai's total assets are 778 million yuan, total liabilities are 523 million yuan, and net assets are 255 million yuan [4]. - Wihua New Materials has faced performance pressures, with a 15.18% decline in revenue to 660 million yuan and a 40.96% drop in net profit to 109 million yuan in the first three quarters of 2025 [4]. Group 3: Strategic Rationale - The acquisition allows Wihua New Materials to bypass lengthy and costly pesticide product registration processes, potentially saving 2-3 years and enabling quicker market entry [2]. - Wihua aims to improve Heyutai's performance by expanding sales channels, enhancing production capacity utilization, optimizing product processes, and strengthening internal management, targeting profitability by 2026 [4].

Group 1 - The company held its fifth board meeting on November 18, 2025, where all seven directors attended and voted on the agenda [2][5][3] - The board approved the acquisition of 70% equity in Jiangsu Heyutai Chemical Co., Ltd. for a cash consideration of 153.86 million yuan, funded by self-owned funds and bank loans [4][11][12] - The acquisition will allow Jiangsu Heyutai to become a wholly-owned subsidiary of the company, enhancing its product value chain and market position [11][15] Group 2 - Jiangsu Heyutai, established in June 2013, specializes in agricultural chemical products and has a registered capital of 120 million yuan [17][25] - The acquisition price was determined based on an asset appraisal that valued 100% of Jiangsu Heyutai's equity at 285.30 million yuan, with a 4.22% increase in value [28][30] - The company aims to leverage Jiangsu Heyutai's existing product lines and customer resources to enhance its operational efficiency and market reach [46][47] Group 3 - The transaction does not constitute a related party transaction or a major asset restructuring, and it does not require shareholder approval [12][16] - The company plans to implement measures to improve Jiangsu Heyutai's performance, which has shown signs of recovery after a period of losses [46][47] - The board's decision was supported by the strategic committee, ensuring compliance with legal and regulatory requirements [6][3]

Core Viewpoint - Wihua New Materials plans to acquire a 70% stake in Jiangsu Heyutai Chemical Co., Ltd. from Zhejiang Xinhai Biological Co., Ltd. for a cash consideration of 154 million yuan, aiming to enhance its competitive position in the agricultural chemicals sector [1][2] Group 1: Acquisition Details - The acquisition will be funded through the company's own funds and bank loans, and after completion, Heyutai will become a subsidiary included in the consolidated financial statements of Wihua New Materials [1] - Heyutai, established in June 2013 with a registered capital of 120 million yuan, specializes in the research, production, and sales of pesticide active ingredients, formulations, and intermediates [1] Group 2: Strategic Rationale - The acquisition aligns with the company's strategy of vertical integration within its supply chain, aiming to extend its product line and enhance overall competitiveness in the industry [1] - By acquiring Heyutai, Wihua New Materials can bypass lengthy and costly pesticide product registration processes, potentially saving 2-3 years and allowing quicker market entry [2] Group 3: Financial Performance and Future Outlook - Heyutai is currently operating at a loss due to fluctuating market prices for agricultural products and underutilization of capacity, but there are signs of improvement, with reduced losses expected in the first half of 2025 compared to the previous year [2] - Wihua New Materials plans to implement measures such as expanding sales channels, improving capacity utilization, optimizing production processes, and enhancing internal management to achieve profitability for Heyutai by 2026 [2] - The acquisition will also ensure a stable supply of key raw materials for Heyutai, which are already sourced from Wihua New Materials and its subsidiaries, thereby reducing procurement uncertainties and improving operational efficiency [2]

Core Viewpoint - Wihua New Materials plans to acquire a 70% stake in He Yu Tai Chemical for 154 million yuan, aiming to enhance its competitiveness in the agricultural chemical sector and extend its product chain [2][3] Group 1: Acquisition Details - The acquisition involves Wihua's subsidiary, Zhejiang Fanghua Chemical, purchasing the stake from Zhejiang Xinhai Biological [2] - The transaction will be funded through self-owned funds and bank loans, with He Yu Tai becoming a controlled subsidiary post-acquisition [2] - He Yu Tai, established in June 2013, specializes in the research, production, and sales of agricultural chemicals, including herbicides and fungicides [2] Group 2: Strategic Rationale - The acquisition is part of Wihua's strategy to vertically extend its industrial chain, enhancing its overall competitiveness in the industry [2] - By acquiring He Yu Tai, Wihua can bypass lengthy and costly pesticide registration processes, potentially saving 2-3 years in market entry time [3] - He Yu Tai has faced losses due to low market prices and underutilization of capacity, but signs of improvement are noted, with reduced losses expected in the first half of 2025 [3] Group 3: Future Plans - Post-acquisition, Wihua aims to improve He Yu Tai's sales channels, capacity utilization, and internal operations to achieve profitability by 2026 [3] - He Yu Tai's current products rely on three main raw materials that are also produced by Wihua, ensuring stable supply and reducing procurement uncertainties [3]

Key Points - The article highlights significant announcements from various companies, including acquisitions, project investments, and share buybacks [1][2] Company Announcements - Zhenai Meijia has no asset restructuring plans for the next twelve months [1] - Geer Software's quantum-resistant encryption products are still in the standardization and pilot application phase, indicating a distance from large-scale commercialization [1] - Xianiao New Energy plans to invest 1.525 billion yuan to construct a project with an annual production capacity of 50,000 tons of high-performance battery materials [1] - Gao Neng Environment has won a contract for a waste-to-energy project in Thailand [1] - Wei Hua New Material intends to acquire 70% of He Yu Tai for 154 million yuan [1] - Zanyu Technology has completed a share buyback of 1.9751% of its shares [1][2] - Aibulu's actual controller plans to reduce his stake by no more than 3% [2] - Wantong Technology plans to raise no more than 920 million yuan through a private placement [2] - Huiyuan Communication aims to raise no more than 610 million yuan through a private placement [1][2]

Group 1 - Shengxin Lithium Energy signed a framework agreement with Huayou Cobalt for the procurement of 221,400 tons of lithium salt products over five years [1] - Wehua New Materials' subsidiary plans to acquire 70% of He Yutai for 154 million yuan [1] - Xiamen Tungsten plans to invest 600 million yuan to establish a wholly-owned subsidiary for a project with an annual production capacity of 50,000 tons of high-performance battery materials [1][2] Group 2 - *ST Songfa's subsidiary signed a shipbuilding contract worth approximately 200-300 million USD for two VLCCs [3] - Hailianxun's stock will resume trading on November 19 after the end of the acquisition request period [5] - Yunnan Energy Investment obtained the development rights for a 25,000 kW wind power project [7] Group 3 - China Resources Double Crane's subsidiary received a drug registration certificate for Oxcarbazepine tablets [8] - Jincheng Pharmaceutical's subsidiary received a CEP certificate for glutathione raw materials [9] - Jinkong Electric plans to transfer 51% of Tongying Thermal Power to an affiliate for 266 million yuan [9] Group 4 - Clean Technology's subsidiary won a bid for a waste incineration power generation project in Thailand with a total investment of up to 4.27 million USD [12] - Tonglian Precision's shareholders set the transfer price for shares at 43.67 yuan each [13] - Hu Nong Commercial Bank's executives collectively purchased 259,100 shares of the company [13] Group 5 - Huatai Medical's subsidiary obtained a medical device registration certificate for polyethylene embolization microspheres [13] - Fosun Pharma's subsidiary's drug registration application was accepted by the National Medical Products Administration [13] - Xianhui Technology signed contracts worth 796 million yuan with multiple subsidiaries of CATL [15] Group 6 - Ningbo Fangzheng signed a strategic cooperation agreement with Huaxiang Qiyuan for the development of various robotic technologies [15] - Ruida Futures' vice president resigned for personal reasons [16] - Samsung Medical is expected to win contracts worth approximately 125 million yuan from the State Grid [17] Group 7 - Tianjin Pharmaceutical's injectable methylprednisolone sodium succinate received registration from Panama's Ministry of Health [19] - Yaxing Anchor Chain plans to invest up to 300 million yuan in a project for deep-sea floating equipment [20] - Zejing Pharmaceutical's clinical trial for ZG006 was approved by the National Medical Products Administration [21] Group 8 - Weiye Co., Ltd. won a bid for a project worth approximately 2.086 billion yuan [23] - Ruimao Tong plans to sell 8.5794 million repurchased shares [25] - Guangge Technology's shareholders plan to reduce their holdings by up to 3.99% [26] Group 9 - Hongsheng Development signed a debt restructuring contract for a total of 2 billion yuan [27][28] - Yatai Co., Ltd. plans to reduce its holdings by up to 1% [30] - Dexin Technology's shareholder plans to reduce its holdings by up to 1% [31] Group 10 - Yaji International's shareholder plans to reduce its holdings by up to 1% [33] - Shenzhen New Star's subsidiary received approval for trial production of a boron trifluoride project [35] - Shengyi Electronics plans to raise up to 2.6 billion yuan through a private placement [36]

证券代码：603310 证券简称：巍华新材 公告编号：2025-062 重要内容提示： 交易简要内容：浙江巍华新材料股份有限公司（以下简称"公司"或"巍 华新材"）控股子公司浙江方华化学有限公司（以下简称"方华化学"）拟以现金 方式收购浙江欣禾生物股份有限公司（以下简称"欣禾生物"）持有的江苏禾裕 泰化学有限公司（以下简称"禾裕泰"或"目标公司"）70%的股权，交易对价 15,386 万元，资金来源为自有资金及银行贷款。本次交易完成后，禾裕泰将成为 公司控股孙公司。 交易实施尚需履行的审批及其他相关程序：本次交易已于 2025 年 11 月 18 日经公司第五届董事会第二次会议审议通过，无需提交股东会审议。 其它需要提醒投资者重点关注的风险事项： 1、禾裕泰目前仍处于亏损阶段，2025 年经营情况有所好转。但仍面临宏观 经济环境、监管政策调整、行业周期性波动、外部市场竞争等影响，可能出现经 营业绩不及预期的风险。 2、本次交易是公司为了延伸现有产品的价值链，从长远发展需要做出的慎 重决策。尽管公司与禾裕泰在产品、市场和技术等方面具有业务协同的基础，但 由于企业文化、管理方式等方面存在一定的差异，公司的运营管理 ...

证券代码：603310 证券简称：巍华新材 公告编号：2025-061 浙江巍华新材料股份有限公司 第五届董事会第二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 （一）审议通过《关于控股子公司收购江苏禾裕泰化学有限公司 70%股权 并签署<股权转让协议>的议案》 董事会同意公司控股子公司浙江方华化学有限公司以现金方式收购浙江欣 禾生物股份有限公司持有的江苏禾裕泰化学有限公司 70%的股权，交易对价 15,386 万元，资金来源为自有资金及银行贷款。本次交易完成后，江苏禾裕泰化 学有限公司将成为公司控股孙公司。 表决结果：7 票同意，0 票反对，0 票弃权，0 票回避。 本议案已经公司董事会战略委员会审议通过，并同意提交董事会审议。 具体内容参见公司同日披露于上海证券交易所网站（www.sse.com.cn）上的 《关于控股子公司收购江苏禾裕泰化学有限公司 70%股权并签署<股权转让协 议>的公告》。 三、备查文件 浙江巍华新材料股份有限公司 浙江巍华新材料股份有限公司（以下简称"公司" ...